Research Article
Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment
Table 3
Complete remission analysis of AML.
| | Characteristics | Total CR rate (%) | CR rate/non-HEHDS guided (%) | CR rate/HEHDS guided (%) | values1 |
| | 48/121 (39.67) | 9/36 (25) | 39/85 (45.88) | 0.025 |
| | New diagnosed | 20/43 (46.51) | 2/10 (20) | 18/33 (54.55) | 0.058 | | Relapsed | 28/78 (35.9) | 7/26 (26.92) | 21/52 (40.1) | 0.181 | | value2 | 0.171 | 0.514 | 0.146 | |
|
|
1Non-HEHDS-guided CR rate vs. HEHDS-guided CR rate. 2The CR rate of new diagnosed vs. the CR rate of relapsed.
|
